The
potentially dilutive securities that have not been included in the calculation of diluted net loss per share as their inclusion
would be anti-dilutive are as follows:
Schedule of anti-dilutive securities excluded from computation of earnings per share
| | |
For the Years Ended September 30, | |
| | |
2024 | | |
2025 | |
| | |
| | | |
| | |
| Number of New Class A Ordinary Shares available for exercise by outstanding warrants * | |
| 208 | | |
| 208 | |
| * |
The share amounts
are presented on a retroactive basis, giving effect to the completion of the share consolidation and re-designation of share
capital on August 25, 2025, the share consolidation on August 6, 2026, and the share consolidation on October 7, 2026 (see
Note 15). The capital reduction effected on July 2, 2026 was not retroactively applied since the capital reduction
occurred after the end of the reporting period (see Note 15). |
|